KPC‐2 producing ST101Klebsiella pneumoniaefrom bloodstream infection in India. Issue 7 (July 2018)

• Record Type: Journal Article
• Authors: Shankar, Chaitra; Shankar, Baby Abirami; Manesh, Abi; Veeraraghavan, Balaji
• Is Part Of: Journal of medical microbiology. Volume 67:Issue 7(2018)
• Publication Date: 2018-07
• Subjects: bacteraemia -- ST101 -- India -- K. pneumoniae -- IncFIIK -- KPC‐2; Medical microbiology -- Periodicals; 616.9041
• DOI: 10.1099/jmm.0.000767
• Languages: English
• ISSNs: 0022-2615

Abstract

Abstract : N/A: This study characterizes KPC‐2 producing Klebsiella pneumoniae belonging to ST101. Whole genome sequencing using the Ion Torrent PGM platform with 400 bp chemistry was performed. bla KPC‐2 was found on an IncFIIK plasmid associated with IS Kpn 6 and IS Kpn 7 without Tn 4401. This is the first report of KPC‐2 K. pneumoniae from bacteremia in India. The isolate also coded for other resistance genes such as aadA1, aadA2, armA, aac(3)‐Ild, aac(6 ′ )‐Ild for aminoglycoside; bla SHV‐11, bla TEM‐1B, bla OXA‐9, for β‐lactams and aac(6 ′ )‐Ild, oqxA, oqxB, qnrB1 for fluoroquinolones. It belonged to the K17 capsular type. India is endemic to New Delhi metallo‐β‐lactamase and OXA48‐like carbapenemases and K. pneumoniae carbapenemase (KPC) is seldom reported. With high rates of carbapenem resistance, emergence of KPC in India will challenge patient management. The isolate was susceptible to colistin. The patient had a fatal outcome.